TTM
$3.22B
YoY change
+6.3%
5Y CAGR
+7.4%
Peak year (2025)
$3.07B
Cumulative revenue
$44.29B
Revenue history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $3.07B
Revenue growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +6.3%
Revenue history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $3.07B | +6.3% | +$181.00M | ||
| 2024 | $2.89B | -2.0% | −$58.40M | ||
| 2023 | $2.95B | +2.3% | +$65.60M | ||
| 2022 | $2.89B | +1.9% | +$54.80M | ||
| 2021 | $2.83B | +31.9% | +$684.00M | ||
| 2020 | $2.15B | +16.4% | +$303.10M | ||
| 2019 | $1.84B | +7.3% | +$125.60M | ||
| 2018 | $1.72B | +7.4% | +$117.80M | ||
| 2017 | $1.60B | +6.0% | +$91.10M | ||
| 2016 | $1.51B | +7.9% | +$111.10M | ||
| 2015 | $1.40B | -1.7% | −$23.70M | ||
| 2014 | $1.42B | +3.9% | +$53.50M | ||
| 2013 | $1.37B | +8.0% | +$101.80M | ||
| 2012 | $1.27B | +6.2% | +$73.80M | ||
| 2011 | $1.19B | +8.0% | +$87.90M | ||
| 2010 | $1.10B | +4.6% | +$49.00M | ||
| 2009 | $1.06B | +0.4% | +$4.60M | ||
| 2008 | $1.05B | +3.0% | +$31.00M | ||
| 2007 | $1.02B | +11.7% | +$106.80M | ||
| 2006 | $913.30M | +30.5% | +$213.60M | ||
| 2005 | $699.70M | +29.2% | +$158.10M | ||
| 2004 | $541.60M | +10.4% | +$50.90M | ||
| 2003 | $490.70M | +16.9% | +$71.00M | ||
| 2002 | $419.70M | +5.7% | +$22.80M | ||
| 2001 | $396.90M | -7.7% | −$33.20M | ||
| 2000 | $430.10M | -8.3% | −$39.00M | ||
| 1999 | $469.10M | +4.3% | +$19.40M | ||
| 1998 | $449.70M | -0.6% | −$2.80M | ||
| 1997 | $452.50M | -1.4% | −$6.30M | ||
| 1996 | $458.80M | +11.1% | +$45.90M | ||
| 1995 | $412.90M | +13.1% | +$47.80M | ||
| 1994 | $365.10M | +4.7% | +$16.40M | ||
| 1993 | $348.70M | +3.1% | +$10.50M | ||
| 1992 | $338.20M | +2.6% | +$8.60M | ||
| 1991 | $329.60M | +2.0% | +$6.40M | ||
| 1990 | $323.20M | +4.7% | +$14.50M | ||
| 1989 | $308.70M | +7.1% | +$20.50M | ||
| 1988 | $288.20M | +13.8% | +$34.90M | ||
| 1987 | $253.30M | +7.5% | +$17.70M | ||
| 1986 | $235.60M | +23.9% | +$45.50M | ||
| 1985 | $190.10M | — | — |
- 2025$3.07B+6.3%
- 2024$2.89B-2.0%
- 2023$2.95B+2.3%
- 2022$2.89B+1.9%
- 2021$2.83B+31.9%
- 2020$2.15B+16.4%
- 2019$1.84B+7.3%
- 2018$1.72B+7.4%
- 2017$1.60B+6.0%
- 2016$1.51B+7.9%
- 2015$1.40B-1.7%
- 2014$1.42B+3.9%
- 2013$1.37B+8.0%
- 2012$1.27B+6.2%
- 2011$1.19B+8.0%
- 2010$1.10B+4.6%
- 2009$1.06B+0.4%
- 2008$1.05B+3.0%
- 2007$1.02B+11.7%
- 2006$913.30M+30.5%
- 2005$699.70M+29.2%
- 2004$541.60M+10.4%
- 2003$490.70M+16.9%
- 2002$419.70M+5.7%
- 2001$396.90M-7.7%
- 2000$430.10M-8.3%
- 1999$469.10M+4.3%
- 1998$449.70M-0.6%
- 1997$452.50M-1.4%
- 1996$458.80M+11.1%
- 1995$412.90M+13.1%
- 1994$365.10M+4.7%
- 1993$348.70M+3.1%
- 1992$338.20M+2.6%
- 1991$329.60M+2.0%
- 1990$323.20M+4.7%
- 1989$308.70M+7.1%
- 1988$288.20M+13.8%
- 1987$253.30M+7.5%
- 1986$235.60M+23.9%
- 1985$190.10M—
Revenue values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current revenue (TTM) is $3.22B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual revenue for West Pharmaceutical Services (WST) came in at $3.07B – grew 6.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, West Pharmaceutical Services revenue compounded at +7.4% per year, with mixed annual results across the window.
2025 marks the peak revenue at $3.07B, with the historical low of $190.10M recorded in 1985.
West Pharmaceutical Services Revenue by Year
West Pharmaceutical Services Revenue 2025: $3.07B
2025's revenue for West Pharmaceutical Services came in at $3.07B, grew 6.3% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Revenue 2024: $2.89B
West Pharmaceutical Services posted revenue of $2.89B in 2024, edged down 2.0% below 2023.
West Pharmaceutical Services Revenue 2023: $2.95B
In 2023, West Pharmaceutical Services reported revenue of $2.95B, edged up 2.3% from 2022.
West Pharmaceutical Services Revenue 2022: $2.89B
West Pharmaceutical Services revenue in 2022 was $2.89B, edged up 1.9% from 2021.
West Pharmaceutical Services Revenue 2021: $2.83B
West Pharmaceutical Services revenue in 2021 was $2.83B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Revenue
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation